Amyloid‐β sequester proteins as blood‐based biomarkers of cognitive decline

Amyloid‐β sequester proteins as blood‐based biomarkers of cognitive decline

Abstract Introduction There are no blood‐based biomarkers for cognitive decline in aging, or mild cognitive impairment (MCI) and Alzheimer's disease (AD). Cumulative evidence suggests that apolipoproteins, complement system, and transthyretin are involved in AD pathogenesis by sequestration of...

Full description

Bibliographic Details
Main Authors: Kazuhiko Uchida, Liu Shan, Hideaki Suzuki, Yo Tabuse, Yoshinori Nishimura, Yoshihiro Hirokawa, Katsuyoshi Mizukami, Hiroyasu Akatsu, Kohji Meno, Takashi Asada
Format: Article
Language:English
Published: Wiley 2015-06-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Alzheimer's disease
Apolipoprotein
Biomarker
Complement system
Diagnostics
Mild cognitive impairment
Online Access:https://doi.org/10.1016/j.dadm.2015.04.003

Internet

https://doi.org/10.1016/j.dadm.2015.04.003

Similar Items